These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 1499366)

  • 1. Recombinant tissue-plasminogen activator (rt-PA) in acute myocardial infarction in the Chinese in Hong Kong.
    Woo KS; Tse KK; Mak YK; Chung HK; Tse CY
    Chin Med J (Engl); 1992 May; 105(5):374-8. PubMed ID: 1499366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant tissue plasminogen activator in acute myocardial infarction in the Chinese in Hong Kong.
    Woo KS; Tse KK; Mak YK; Chung HK; Tse CY
    Int J Cardiol; 1992 Aug; 36(2):169-76. PubMed ID: 1512055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction.
    Bassand JP; Cariou R; Grollier G; Kragten J; Wolf JE; Heyndrickx GR
    Semin Thromb Hemost; 1999; 25 Suppl 2():69-75. PubMed ID: 10440428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
    Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
    Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
    Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
    Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Brazilian study with alteplase in acute myocardial infarction--EBRALT].
    Batlouni M; Jorge Sdo C; Piegas LS
    Arq Bras Cardiol; 1995 Aug; 65(2):175-9. PubMed ID: 8554497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory assessment of thrombolytic therapy in acute myocardial infarction.
    Talalak P; Chaithiraphan S; Opartkiattikul N; Leowattana W; Sangtawesin W; Tresukosol D
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():144-8. PubMed ID: 7886558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Randomized double-blind study comparing tissue-type plasminogen activator with placebo in acute myocardial infarct].
    Bleifeld W; Verstraete M; Brower RW; Collen D; Dunning AJ; Lubsen J; Michel PL; Schofer J; Vanhaecke J; Van de Werf F
    Klin Wochenschr; 1988; 66 Suppl 12():86-92. PubMed ID: 3126349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator.
    Glazier JJ; Crowley J; Cremin D; Coll T; Daly K
    Ir Med J; 1989 Sep; 82(3):111-4. PubMed ID: 2513287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 hours after recombinant tissue-type plasminogen activator for acute myocardial infarction. National Heart Foundation of Australia Coronary Thrombolysis Group.
    Thompson PL; Aylward PE; Federman J; Giles RW; Harris PJ; Hodge RL; Nelson GI; Thomson A; Tonkin AM; Walsh WF
    Circulation; 1991 May; 83(5):1534-42. PubMed ID: 1902404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of recombinant tissue plasminogen activator infusion in acute myocardial infarction.
    Wang SP; Liu CP; Charng MJ; Chou CY; Tsai JH; Pan JP; Shyong WC; Chan WL; Kong CW; Chang MS
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Apr; 43(4):223-8. PubMed ID: 2509051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of event-free survival after hospital discharge in acute myocardial infarction treated with tissue-plasminogen activator.
    Brzostek T; Van de Werf F; Scheys I; Lesaffre E; Dubiel J; De Geest H
    Acta Cardiol; 1994; 49(1):9-24. PubMed ID: 8184642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year follow-up after recombinant tissue plasminogen activator administered to patients with acute myocardial infarction.
    McNeill AJ; Dickey W; Campbell NP; Khan MM; Patterson GC; Webb SW; Adgey AA
    Eur Heart J; 1991 May; 12(5):624-9. PubMed ID: 1908384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant tissue plasminogen activator (rt-PA).
    Epstein C
    Aust Nurses J; 1992 Mar; 21(8):29-30. PubMed ID: 1605783
    [No Abstract]   [Full Text] [Related]  

  • 18. Intermittent, dose-related fluctuations of pain and ST elevation during infusion of recombinant tissue plasminogen activator during acute myocardial infarction.
    Barbash GI; Hod H; Rath S; Miller HI; Roth A; Har-Zahav Y; Modan M; Rotstein Z; Batler A; Zivelin A
    Am J Cardiol; 1989 Jul; 64(3):225-8. PubMed ID: 2500841
    [No Abstract]   [Full Text] [Related]  

  • 19. Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience.
    Sloan MA; Price TR; Terrin ML; Forman S; Gore JM; Chaitman BR; Hodges M; Mueller H; Rogers WJ; Knatterud GL; Braunwald E
    Stroke; 1997 Jun; 28(6):1107-14. PubMed ID: 9183334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein (a) levels do not influence the outcome of rt-PA therapy in acute myocardial infarction.
    Tranchesi B; Santos Filho R; Vinagre C; Caramelli B; Barbosa V; Gebara O; Belloti G; Pileggi F; Maranhão R
    Ann Hematol; 1991 Apr; 62(4):141-2. PubMed ID: 1827740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.